Loss of Lipitor Leaves Pfizer (PFE) Limping Following Q1 Numbers; Cuts FY12 Outlook

Go back to Loss of Lipitor Leaves Pfizer (PFE) Limping Following Q1 Numbers; Cuts FY12 Outlook